Nukkleus Inc

Nukkleus Inc (NUKK) Financials

$2.060

+0.173 (+8.42%)At close

NUKK Comparative Benchmarking

In the context of the broader market, NUKK competes directly with industry leaders such as CREX and UBXG. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, NUKK's gross margin of N/A stands against CREX's 38.58% and UBXG's 0.26%. Such benchmarking helps identify whether Nukkleus Inc is trading at a premium or discount relative to its financial performance.

Nukkleus Inc Financial Performance

- Latest quarter: 2025/Q3.

- Revenue: 0 (down -100% YoY) → severe top-line deterioration.

- Net income: -16,365,492 (loss; “improved” YoY but still deeply negative).

- EPS: -2.01 (improved YoY, but remains meaningfully negative).

- Gross margin: 0 (down -100% YoY), consistent with the revenue collapse and/or lack of operating throughput.

Financials

FY2025Q3
YoY:
-100.00%
0.00
Total Revenue
FY2025Q3
YoY:
+242.87%
-4.77M
Operating Profit
FY2025Q3
YoY:
+908.84%
-16.30M
Net Income after Tax
FY2025Q3
YoY:
+123.33%
-2.01
EPS - Diluted
FY2025Q3
YoY:
+435.68%
-3.97M
Free Cash Flow
FY2024Q3
YoY:
-1765.35%
71.61
Gross Profit Margin - %
FY2024Q3
YoY:
+3874.32%
-922.44
Net Margin - %

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started